1-indazolyl ketone derivatives (Cajal Institute)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Name1-indazolyl ketone derivatives (Cajal Institute)
Drug Alias NameNP-137 (Cajal Institute)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB2 receptor agonistsBeta-secretase 1 inhibitorsCholinesterase inhibitors
TargetsCholinesteraseCannabinoid CB2 receptorBeta-secretase 1
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCajal Institute
China Registration ClassN/A

Develop Information

Active CompaniesCajal Institute
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A